Myovant Sciences Ltd.

06/17/2022 | Press release | Distributed by Public on 06/17/2022 04:54

Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With[...]